Coronavirus Update: After Green Light In Canada, US Awaits Pfizer/BioNTech Vaccine Authorization
Plus: Changes At UK Taskforce
Pfizer and BioNTech's COVID-19 vaccine picks up its third emergency authorization, with all eyes now on the final decision from the US FDA. Elsewhere, there are changes at the UK's vaccine taskforce, while Korea is moving ahead with vaccine development plans.
You may also be interested in...
Individuals with history of significant allergic reactions are now being told not to have the vaccine after warnings were not included in healthcare professional information.
The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
The UK has built one of the biggest and best ‘portfolios’ of COVID-19 vaccine candidates – but there are questions about its transparency and accountability.